$BIIB
BIOGEN INC. Stock $biib

$biib Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000087504517000024 Filed on July 25, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$3.078B	$2.894B
YoY Change	6.36%	11.68%
Cost Of Revenue	$366.2M	$370.3M
YoY Change	-1.11%	29.43%
Gross Profit	$2.712B	$2.524B
YoY Change	7.46%	9.47%
Gross Profit Margin	88.1%	87.21%
Selling, General & Admin	$429.8M	$492.4M
YoY Change	-12.71%	0.1%
% of Gross Profit	15.85%	19.51%
Research & Development	$796.2M	$473.1M
YoY Change	68.29%	-3.59%
% of Gross Profit	29.36%	18.74%
Depreciation & Amortization	$302.6M	$175.4M
YoY Change	72.52%	21.3%
% of Gross Profit	11.16%	6.95%
Operating Expenses	$1.226B	$965.5M
YoY Change	26.98%	-1.74%
Operating Profit	$1.201B	$1.461B
YoY Change	-17.77%	18.44%
Interest Expense	$63.60M	$65.90M
YoY Change	-3.49%	1036.21%
% of Operating Profit	5.3%	4.51%
Other Income/Expense, Net	-$68.60M	-$58.50M
YoY Change	17.26%	436.7%
Pretax Income	$1.132B	$1.402B
YoY Change	-19.23%	14.71%
Income Tax	$269.6M	$353.6M
% Of Pretax Income	23.81%	25.22%
Net Earnings	$862.8M	$1.050B
YoY Change	-17.81%	13.21%
Net Earnings / Revenue	28.03%	36.27%
Basic Earnings Per Share	$4.07	$4.79
Diluted Earnings Per Share	$4.07	$4.79
COMMON SHARES
Basic Shares Outstanding	211.9M shares	219.1M shares
Diluted Shares Outstanding	212.2M shares	219.4M shares

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.893B	$3.797B
YoY Change	-23.81%	60.28%
Cash & Equivalents	$1.170B	$1.362B
Short-Term Investments	$1.724B	$2.435B
Other Short-Term Assets	$1.146B	$1.027B
YoY Change	11.55%	36.98%
Inventory	$936.5M	$996.4M
Prepaid Expenses
Receivables	$1.630B	$1.293B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$7.109B	$7.448B
YoY Change	-4.55%	32.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.828B	$2.302B
YoY Change	22.84%	25.26%
Goodwill	$3.870B	$3.167B
YoY Change	22.21%	47.01%
Intangibles	$4.051B	$3.968B
YoY Change	2.11%	-7.62%
Long-Term Investments	$3.901B	$4.592B
YoY Change	-15.05%	60.95%
Other Assets	$1.268B	$1.153B
YoY Change	10.0%	53.41%
Total Long-Term Assets	$14.65B	$14.07B
YoY Change	4.15%	26.27%
TOTAL ASSETS
Total Short-Term Assets	$7.109B	$7.448B
Total Long-Term Assets	$14.65B	$14.07B
Total Assets	$21.76B	$21.51B
YoY Change	1.14%	28.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$330.3M	$225.9M
YoY Change	46.22%	-20.09%
Accrued Expenses	$1.077B	$903.0M
YoY Change	19.27%	9.72%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$560.0M	$5.000M
YoY Change	11100.0%	66.67%
Total Short-Term Liabilities	$3.380B	$2.516B
YoY Change	34.32%	-1.55%
LONG-TERM LIABILITIES
Long-Term Debt	$5.954B	$6.538B
YoY Change	-8.93%	1035.07%
Other Long-Term Liabilities	$750.9M	$951.0M
YoY Change	-21.04%	3.85%
Total Long-Term Liabilities	$750.9M	$951.0M
YoY Change	-21.04%	3.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.380B	$2.516B
Total Long-Term Liabilities	$750.9M	$951.0M
Total Liabilities	$10.19B	$10.11B
YoY Change	0.73%	141.54%
SHAREHOLDERS EQUITY
Retained Earnings	$14.88B	$14.23B
YoY Change	4.59%	28.96%
Common Stock	$100.0K	$100.0K
YoY Change	0.0%	-22.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.977B	$2.612B
YoY Change	13.99%	0.0%
Treasury Stock Shares
Shareholders Equity	$11.59B	$11.40B
YoY Change
Total Liabilities & Shareholders Equity	$21.76B	$21.51B
YoY Change	1.14%	28.38%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	$862.8M	$1.050B
YoY Change	-17.81%	13.21%
Depreciation, Depletion And Amortization	$302.6M	$175.4M
YoY Change	72.52%	21.3%
Cash From Operating Activities	$1.169B	$998.2M
YoY Change	17.13%	-4.69%
INVESTING ACTIVITIES
Capital Expenditures	-$322.8M	-$108.2M
YoY Change	198.34%	-16.71%
Acquisitions
YoY Change
Other Investing Activities	$120.2M	-$627.9M
YoY Change	-119.14%	-44.11%
Cash From Investing Activities	-$202.6M	-$736.1M
YoY Change	-72.48%	-41.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-751.0M	-15.80M
YoY Change	4653.16%	338.89%
NET CHANGE
Cash From Operating Activities	1.169B	998.2M
Cash From Investing Activities	-202.6M	-736.1M
Cash From Financing Activities	-751.0M	-15.80M
Net Change In Cash	215.6M	246.3M
YoY Change	-12.46%	-217.51%
FREE CASH FLOW
Cash From Operating Activities	$1.169B	$998.2M
Capital Expenditures	-$322.8M	-$108.2M
Free Cash Flow	$1.492B	$1.106B
YoY Change	34.85%	-6.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.260
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.090
	biib	Adjustments To Product Revenue Reserves Relating To Sales In Prior Years AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears	-1500000	USD
CY2016Q4	biib	Available For Sale Securities Debt Maturities After Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost	277500000	USD
CY2017Q2	biib	Available For Sale Securities Debt Maturities After Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost	255200000	USD
CY2016Q4	biib	Available For Sale Securities Debt Maturities After Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue	276800000	USD
CY2017Q2	biib	Available For Sale Securities Debt Maturities After Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue	255100000	USD
CY2016	biib	Average Maturity Of Marketable Securities AverageMaturityOfMarketableSecurities	P12M
	biib	Average Maturity Of Marketable Securities AverageMaturityOfMarketableSecurities	P17M
CY2016Q4	biib	Collaborationexpensesaccrual Collaborationexpensesaccrual	130900000	USD
CY2017Q2	biib	Collaborationexpensesaccrual Collaborationexpensesaccrual	188000000	USD
CY2016Q2	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	-5600000	USD
	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	-5600000	USD
CY2017Q2	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	26500000	USD
	biib	Collaborationprofitlosssharing Collaborationprofitlosssharing	47300000	USD
	biib	Current Provisions To Product Revenue Reserves Relating To Sales In Current Year CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear	1412100000	USD
CY2016Q4	biib	Duefromanti Cd20therapeuticprograms DuefromantiCD20therapeuticprograms	300600000	USD
CY2017Q2	biib	Duefromanti Cd20therapeuticprograms DuefromantiCD20therapeuticprograms	502900000	USD
CY2016Q2	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.016
	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.017
CY2017Q2	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.021
	biib	Effective Income Tax Rate Reconciliation Manufacturing Deduction EffectiveIncomeTaxRateReconciliationManufacturingDeduction	-0.021
	biib	Interest In Subsidiary InterestInSubsidiary	1.00
CY2016Q4	biib	Inventorynetcurrentandnoncurrent Inventorynetcurrentandnoncurrent	1039400000	USD
CY2017Q2	biib	Inventorynetcurrentandnoncurrent Inventorynetcurrentandnoncurrent	961800000	USD
CY2016Q4	biib	Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities	47400000	USD
CY2017Q2	biib	Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities	53100000	USD
	biib	Payments Returns Applied Against Product Revenue Reserves Relating To Current Year PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear	836400000	USD
	biib	Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear	458400000	USD
	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	97000000	USD
CY2016Q4	biib	Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax	49800000	USD
CY2017Q2	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	34000000	USD
	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	79400000	USD
	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	737700000	USD
CY2016Q2	biib	Share Based Compensation Expense Included In Costs And Expenses ShareBasedCompensationExpenseIncludedInCostsAndExpenses	45800000	USD
CY2016Q2	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	349200000	USD
	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	678700000	USD
CY2017Q2	biib	Revenuesfromanti Cd20therapeuticprograms RevenuesfromantiCD20therapeuticprograms	397100000	USD
CY2017Q2	biib	Unrealized Gain Losses On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax	77400000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000875045
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	211431746	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	BIOGEN INC.
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	279800000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	330300000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1441600000	USD
CY2017Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1630200000	USD
CY2016Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	195800000	USD
CY2017Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	195800000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1439300000	USD
CY2017Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1511400000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-224000000	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-282800000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-319900000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-338800000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	0	USD
CY2017Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19300000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	50200000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	104500000	USD
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	36400000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	84500000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	92900000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	181700000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	117500000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	566000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2016Q4	us-gaap	Assets Assets	22876800000	USD
CY2017Q2	us-gaap	Assets Assets	21759000000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	8732200000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	7108700000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	5406300000	USD
CY2017Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	4361100000	USD
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	5398000000	USD
CY2017Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	4356200000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2900000	USD
CY2017Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3500000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	11200000	USD
CY2017Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	8400000	USD
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	5406300000	USD
CY2017Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	4361100000	USD
CY2016Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	2568600000	USD
CY2017Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	1723500000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	2559700000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	2381100000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	2552600000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	2377600000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	2569100000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	1724800000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2568600000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1723500000	USD
CY2016Q2	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	600000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	1000000	USD
CY2017Q2	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	1200000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	2400000	USD
CY2016Q2	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	1200000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	1600000	USD
CY2017Q2	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	1300000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	3200000	USD
CY2016Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	2829400000	USD
CY2017Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	2632700000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	580800000	USD
CY2017Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	580700000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	246800000	USD
CY2017Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	265800000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1308000000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1362000000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2326500000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1169500000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	53900000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1194800000	USD
CY2016Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2039600000	USD
CY2017Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	836000000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	100000	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	100000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1026300000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1961900000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	849200000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1591500000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1400000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3100000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	100000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1024900000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1958800000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	849200000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1591400000	USD
CY2016Q4	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	134000000	USD
CY2017Q2	us-gaap	Construction Payable Current And Noncurrent ConstructionPayableCurrentAndNoncurrent	161300000	USD
CY2016Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	370300000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	683300000	USD
CY2017Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	366200000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	750800000	USD
CY2016Q2	us-gaap	Costs And Expenses CostsAndExpenses	1433700000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	2782100000	USD
CY2017Q2	us-gaap	Costs And Expenses CostsAndExpenses	1877800000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	3664200000	USD
CY2016Q4	us-gaap	Debt Current DebtCurrent	4700000	USD
CY2017Q2	us-gaap	Debt Current DebtCurrent	559900000	USD
CY2016Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	6808400000	USD
CY2017Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	7006000000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-30200000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-20500000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	93100000	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	100800000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	325100000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	814600000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.79
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.23
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.53
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.79
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.21
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.52
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	100000	USD
CY2017Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.100
CY2017Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.238
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.240
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	37800000	USD
CY2016Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.252
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2017Q2	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.117
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.114
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.011
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.011
CY2017Q2	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.014
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.014
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.006
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.006
CY2017Q2	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.007
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.007
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002
CY2017Q2	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.006
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.008
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.010
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.010
CY2017Q2	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.008
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.004
CY2016Q2	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.012
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.012
CY2017Q2	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.009
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.008
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	282900000	USD
CY2017Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	186600000	USD
CY2016Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	4400000	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	7500000	USD
CY2017Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	2400000	USD
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	5100000	USD
CY2016Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	12700000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	27900000	USD
CY2017Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	8500000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	20900000	USD
CY2016Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-10600000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-12900000	USD
CY2017Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-21200000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-31200000	USD
CY2016Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
CY2017Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
CY2016Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	3200000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	3200000	USD
CY2017Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	6700000	USD
	us-gaap	Fair Value Measurements Changes In Valuation Techniques FairValueMeasurementsChangesInValuationTechniques	0
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3934000000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4167000000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	425800000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	222600000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	216700000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	239300000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	378600000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	412500000	USD
CY2016Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	200000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2300000	USD
CY2017Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2300000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1700000	USD
CY2016Q2	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	18600000	USD
	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	16200000	USD
CY2017Q2	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	6100000	USD
	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	4500000	USD
CY2016Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-2700000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-1100000	USD
CY2017Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-13400000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-11000000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	3669300000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	3870400000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	508900000	USD
CY2017Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	USD
	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	6300000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1402000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2727600000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1132400000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2119100000	USD
CY2016Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2017Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	353600000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	710000000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	269600000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	508800000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	65000000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	301200000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-76700000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-114700000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-116400000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-452300000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	128300000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	85300000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	25100000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	187300000	USD
CY2016Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	7742300000	USD
CY2017Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	8218300000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3808300000	USD
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4051300000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	65900000	USD
	us-gaap	Interest Expense InterestExpense	129200000	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	63600000	USD
	us-gaap	Interest Expense InterestExpense	127000000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	170300000	USD
CY2017Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	184200000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	1001600000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	936500000	USD
CY2016Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	37800000	USD
CY2017Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	25300000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	170400000	USD
CY2017Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	148300000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	698700000	USD
CY2017Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	629300000	USD
CY2016Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	15400000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	26600000	USD
CY2017Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	16900000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	33600000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	10748200000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	10185400000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22876800000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21759000000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3419900000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3379700000	USD
CY2016Q4	us-gaap	Litigation Reserve LitigationReserve	454800000	USD
CY2017Q2	us-gaap	Litigation Reserve LitigationReserve	0	USD
	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	1250000000	USD
CY2016	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	454800000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	6512700000	USD
CY2017Q2	us-gaap	Long Term Debt LongTermDebt	5954000000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	2100000	USD
CY2016Q1	us-gaap	Minority Interest MinorityInterest	1300000	USD
CY2016Q2	us-gaap	Minority Interest MinorityInterest	-100000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	-11500000	USD
CY2017Q1	us-gaap	Minority Interest MinorityInterest	-11600000	USD
CY2017Q2	us-gaap	Minority Interest MinorityInterest	-11600000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-20800000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1652400000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1939300000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-946800000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2014000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1404400000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	1049800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	2020700000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	862800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1610400000	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1400000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3100000	USD
CY2017Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-100000	USD
CY2016Q2	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	0	USD
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	900000	USD
CY2017Q2	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	0	USD
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	0	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-58500000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-111300000	USD
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-68200000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-105800000	USD
CY2016Q4	us-gaap	Notes Payable NotesPayable	6499300000	USD
CY2017Q2	us-gaap	Notes Payable NotesPayable	6496600000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1460500000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	2838900000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1200600000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	2224900000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	685700000	USD
CY2017Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	591200000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1093300000	USD
CY2017Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1146100000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1335800000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1268300000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	4500000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	7000000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	7200000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	5600000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-54800000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-15400000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	29300000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-18300000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-103000000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-126800000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-58000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-48400000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	82800000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	102800000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-23500000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-58800000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-13600000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-18900000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-700000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-900000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	600000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	500000	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2903500000	USD
CY2017Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2436900000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	722500000	USD
CY2017Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	750900000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-28900000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-73500000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5500000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9900000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5800000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3100000	USD
CY2016Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	79000000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	166900000	USD
CY2017Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	41600000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	131600000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	65900000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7300000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1365400000	USD
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	0	USD
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	302700000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	21900000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	17800000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	3833300000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2536000000	USD
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	0	USD
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	120000000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	860300000	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	600000000	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	600000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	263700000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	407700000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Taxes PrepaidTaxes	817000000	USD
CY2017Q2	us-gaap	Prepaid Taxes PrepaidTaxes	881400000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	1100000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	33500000	USD
CY2016Q2	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	1642500000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	2823600000	USD
CY2017Q2	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	1700200000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	3584500000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	1048400000	USD
	us-gaap	Profit Loss ProfitLoss	2017600000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	862800000	USD
	us-gaap	Profit Loss ProfitLoss	1610300000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2501800000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2827600000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-4000000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-3500000	USD
CY2016Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	473100000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	910400000	USD
CY2017Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	796200000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1219600000	USD
CY2016Q2	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2017Q2	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	120000000	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	120000000	USD
CY2016Q2	us-gaap	Restructuring Charges RestructuringCharges	0	USD
	us-gaap	Restructuring Charges RestructuringCharges	9700000	USD
CY2017Q2	us-gaap	Restructuring Charges RestructuringCharges	0	USD
	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15071600000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	14881700000	USD
CY2016Q2	us-gaap	Revenues Revenues	2894200000	USD
	us-gaap	Revenues Revenues	5621000000	USD
CY2017Q2	us-gaap	Revenues Revenues	3078400000	USD
	us-gaap	Revenues Revenues	5889100000	USD
CY2016Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2466000000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	4775400000	USD
CY2017Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2639700000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5019800000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	492400000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	989700000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	430200000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	929300000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	84100000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	67300000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	12140100000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	11585200000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12128600000	USD
CY2017Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11573600000	USD
	us-gaap	Stockholders Equity Note Spinoff Transaction StockholdersEquityNoteSpinoffTransaction	852800000	USD
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	555000000	USD
CY2016Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	231900000	USD
CY2017Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	52600000	USD
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2611700000	USD
CY2017Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2977100000	USD
CY2016Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	605500000	USD
CY2017Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	724300000	USD
CY2016Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	300000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	300000	shares
CY2017Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	300000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	300000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	219400000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	219300000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	212200000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	214000000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	219100000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	219000000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	211900000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	213700000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The preparation of our condensed consolidated financial statements requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and expenses. Actual results may differ from these estimates under different assumptions or conditions.</font></div></div>

Files In Submission

Name	View Source	Status
0000875045-17-000024-index-headers.html	Edgar Link	pending
0000875045-17-000024-index.html	Edgar Link	pending
0000875045-17-000024.txt	Edgar Link	pending
0000875045-17-000024-xbrl.zip	Edgar Link	pending
biib-20170630.xml	Edgar Link	completed
biib-20170630.xsd	Edgar Link	pending
biib-20170630_cal.xml	Edgar Link	unprocessable
biib-20170630_def.xml	Edgar Link	unprocessable
biib-20170630_lab.xml	Edgar Link	unprocessable
biib-20170630_pre.xml	Edgar Link	unprocessable
biib-2017630acquirediprd.jpg	Edgar Link	pending
biib-2017630amortization.jpg	Edgar Link	pending
biib-2017630anticd20.jpg	Edgar Link	pending
biib-2017630biosimilars.jpg	Edgar Link	pending
biib-2017630collaborationps.jpg	Edgar Link	pending
biib-2017630cos.jpg	Edgar Link	pending
biib-2017630highlights.jpg	Edgar Link	pending
biib-2017630incometax.jpg	Edgar Link	pending
biib-2017630interferon.jpg	Edgar Link	pending
biib-2017630oie.jpg	Edgar Link	pending
biib-2017630otherrevenues.jpg	Edgar Link	pending
biib-2017630rd.jpg	Edgar Link	pending
biib-2017630rdpie2016.jpg	Edgar Link	pending
biib-2017630rdpie2017.jpg	Edgar Link	pending
biib-2017630reserves.jpg	Edgar Link	pending
biib-2017630sga.jpg	Edgar Link	pending
biib-2017630spinraza.jpg	Edgar Link	pending
biib-2017630tecfidera.jpg	Edgar Link	pending
biib-2017630tysabri.jpg	Edgar Link	pending
biib-2017630x10q.htm	Edgar Link	pending
biib-2017630xex311.htm	Edgar Link	pending
biib-2017630xex312.htm	Edgar Link	pending
biib-2017630xex321.htm	Edgar Link	pending
biib-2017630xexhibit102.htm	Edgar Link	pending
biib-2017630xexhibit103.htm	Edgar Link	pending
biib-2017630xexhibit104.htm	Edgar Link	pending
biib-2017630xexhibit105.htm	Edgar Link	pending
biib-2017630zinbryta.jpg	Edgar Link	pending
biogenlogostandarda05.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BIIB
BIOGEN INC. Stock $biib

2017 Q2 Form 10-Q Financial Statement

#000087504517000024 Filed on July 25, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIIB BIOGEN INC. Stock $biib

2017 Q2 Form 10-Q Financial Statement

#000087504517000024 Filed on July 25, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIIB
BIOGEN INC. Stock $biib